Cimpress stock: fair value
CMPRThe fair value of Cimpress under our model is $99.73, the price is 43% below.
The fair value is an estimate from our model, not a price target.
Daily figure as of 13 Nov 2026
Valuation signal
Possible value trapIn our model the price counts as cheap below $71.23 and expensive above $166.21 (uncertainty high, based on the price swings of the past year).
The two parts of the fair value come to $126.98 (cash-flow model) and $72.48 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is below both.
Calculated with a cost of equity of 12%. At 13% the fair value would be $92.53, at 11% it would be $108.96.
Possible value trap: looks cheap, but high risk.
Where the number comes from
Half from the cash-flow model, half from earnings times the industry P/E (20.7).
Ten-year cash-flow model from smoothed free cash flow and its past growth until it reaches 3.8%. Discounted at 12.0% (government bond yield 3.8% plus beta 1.62 times a risk premium of 5%); no analyst estimates were available.
Calculate with your own assumptionsThe calculation step by step
With these figures the cash flow model arrives at $126.98 per share: free cash flow for the next ten years, each year discounted to today at 12.0%, plus the terminal value for the years after. The table explains the calculation; it is not a recommendation.
Calculation as a table
| Year | Free cash flow | Source | Discount factor | Present value (discounted at 12.0%) |
|---|---|---|---|---|
| 2027 | $208.17M | extrapolated at 15.0% | 0.8932 | $185.94M |
| 2028 | $232.48M | extrapolated at 11.7% | 0.7978 | $185.48M |
| 2029 | $254.16M | extrapolated at 9.3% | 0.7126 | $181.12M |
| 2030 | $273.67M | extrapolated at 7.7% | 0.6365 | $174.2M |
| 2031 | $291.52M | extrapolated at 6.5% | 0.5685 | $165.75M |
| 2032 | $308.18M | extrapolated at 5.7% | 0.5078 | $156.51M |
| 2033 | $324.05M | extrapolated at 5.1% | 0.4536 | $146.99M |
| 2034 | $339.46M | extrapolated at 4.8% | 0.4052 | $137.54M |
| 2035 | $354.65M | extrapolated at 4.5% | 0.3619 | $128.35M |
| 2036 | $369.84M | extrapolated at 4.3% | 0.3232 | $119.55M |
| Step | Value |
|---|---|
| Sum of present values (ten years) | $1.58B |
| Terminal value: cash flow 2036 × (1 + 3.8%) / (12.0% − 3.8%) | $4.73B |
| Present value of terminal value (× 0.3232) | $1.53B |
| Equity value (sum plus present value of terminal value) | $3.11B |
| Shares (diluted) | 24.48M |
| Value per share (equity value divided by shares) | $126.98 |
| Earnings per share, last twelve months | $3.49 |
| × 20.7 (industry P/E) | $72.48 |
| Fair value (average of both parts) | $99.73 |
The model uses free cash flow after interest, which belongs to shareholders, discounted at the cost of equity. Net debt is therefore not deducted again.
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 30 Jun 2026
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 3 Oct 2025)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.